Do patients with immune-mediated thrombotic thrombocytopenic purpura receiving caplacizumab need antithrombotic therapy?

Author
ELVERDİ, Tuğrul
EŞKAZAN, Ahmet Emre
Aydin, Tahacan
Ozer Cerme, Melis Dila
Metadata
Show full item record
URI
http://hdl.handle.net/20.500.12627/168905
https://doi.org/10.1080/17512433.2021.1944102
Collections